Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. PI Pharma Inc
WARNING LETTER
•PI Pharma Inc•February 19, 2014

PI Pharma Inc – FDA Warning Letter, Feb 19, 2014

Record Details

On February 10-19, 2014, the FDA inspected PI Pharma Inc. (dba Nature's Extra) and found serious violations. Products "Argentia Silver Cream" and "(b)(4)" are unapproved new drugs under 21 U.S.C. § 321(g)(1) and § 321(p) due to therapeutic claims (e.g., "Wound Healing," "Genital Wart Treatment"). Their distribution without FDA-approved applications violates 21 U.S.C. §§ 331(d) and 355(a). "(b)(4)" is also misbranded under 21 U.S.C. § 352(f)(1) for lacking adequate directions for use, as genital warts are not amenable to self-treatment.

The inspection also revealed significant Current Good Manufacturing Practice (CGMP) violations for dietary supplements (21 CFR Part 111), rendering "(b)(4)" dietary supplements adulterated (21 U.S.C. § 342(g)(1)). Violations include: 1. Failure to establish and verify finished product specifications (21 CFR 111.70(e), 111.75(c)). 2. Failure to establish specifications for products received for packaging/labeling (21 CFR 111

Company
PI Pharma Inc
Inspection date
February 19, 2014
Product type
Drugs
Office
Cincinnati District Office
Person
  • Paul J. Teitell (District Director)
View Company Profile

ID · 4a90e924-9f1d-47b1-83a6-65f0bb8a0c57

Violation Codes10
21 U.S.C. 331(d)21.U.S.C. 355(a)21 CFR 201.521 CFR 201.100(c)(2)21 CFR 111.70(e)21 CFR 111.75(c)21 CFR 111.7321 CFR 111.255(b)21 CFR 111.260(b)21 CFR 211.165(a)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore PI Pharma Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.